Hepatología: Metabolismo, Epigenética y Carcinogénesis
METACAN
Universidade de Lisboa
Lisboa, PortugalPublikationen in Zusammenarbeit mit Forschern von Universidade de Lisboa (6)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
2022
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
2020
-
A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
Cancers, Vol. 12, Núm. 6
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
-
Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting
Gut, Vol. 69, Núm. 4, pp. 764-780